Literature DB >> 4026061

Choosing an appropriate cutting point for conversion in annual tuberculin skin testing.

J B Bass, R V Sanders, M B Kirkpatrick.   

Abstract

A previous report from our institution showed that the use of a two-step tuberculin testing program in new employees reduced the apparent rate of conversion in annual skin testing by eliminating the effect of the booster phenomenon. However, the converter rate subsequently remained too high. We propose that the use of 10 mm of induration as the cutting point gave a high rate of false conversion in our area of high prevalence of sensitivity to nontuberculous mycobacteria. A change to 15 mm of duration as the cutting point reduced our conversion rate from 2.6 to 1.2%, identified a group who demonstrated continued large tuberculin reactions at repeat testing, and eliminated age dependency from our converter population. We propose the choice of 15 mm of induration as the appropriate cutting point in annual employee tuberculin skin testing programs in areas in which sensitivity to nontuberculous mycobacteria is common.

Mesh:

Year:  1985        PMID: 4026061     DOI: 10.1164/arrd.1985.132.2.379

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  4 in total

1.  New guidelines for tuberculin skin test interpretation.

Authors:  J E Rodnick
Journal:  West J Med       Date:  1991-03

2.  Unrecognised transmission of tuberculosis in prisons.

Authors:  C R MacIntyre; N Kendig; L Kummer; S Birago; N M Graham; A J Plant
Journal:  Eur J Epidemiol       Date:  1999-09       Impact factor: 8.082

3.  Use of Mycobacterium tuberculosis complex-specific antigen cocktails for a skin test specific for tuberculosis.

Authors:  K Lyashchenko; C Manca; R Colangeli; A Heijbel; A Williams; M L Gennaro
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

4.  Discordance of tuberculin skin test and interferon gamma release assay in recently exposed household contacts of pulmonary TB cases in Brazil.

Authors:  Rodrigo Ribeiro-Rodrigues; Soyeon Kim; Flávia Dias Coelho da Silva; Aleksandra Uzelac; Lauren Collins; Moíses Palaci; David Alland; Reynaldo Dietze; Jerrold J Ellner; Edward Jones-López; Padmini Salgame
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.